Investigative Site 124 — Normal, Illinois

Investigative Site 124 is a clinical research site located in Normal, Illinois, United States 61761.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigative Site 124 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Urticaria Chronic.

Sponsors: Jasper Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Normal

Browse all research sites in Illinois · View every site in Normal

• Advocate Health and Hospitals Corp
• Bromenn Regional Medical Center
• Community Cancer Center
• Carle Cancer Institute Normal
• Illinois CancerCare-Community Cancer Center
• Carle BroMenn Medical Center
• Community Cancer Center Foundation
• Sneeze, Wheeze & Itch Associates
• Sneeze Wheeze and Itch Associates
• Research Site
• GSK Investigational Site
• Midwest Allergy Sinus Asthma SC

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigative Site 124?

Investigative Site 124 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigative Site 124 conducted?

Investigative Site 124 has 1 clinical trials on record, with 1 currently active. Their work covers Urticaria Chronic.

Is Investigative Site 124 accredited by Crixeo Clinical Trials?

Investigative Site 124 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigative Site 124?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.